The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host

Cancer and Metastasis Reviews

Volumn 27, Issue 4, 2008, Pages 691-705

  Podhajcer, Osvaldo L ^a,b   Benedetti, Lorena Gabriela ^a   Girotti, Maria Romina ^a   Prada, Federico ^a,c   Salvatierra, Edgardo ^a   Llera, Andrea S ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^c UNIVERSIDAD ARGENTINA DE LA EMPRESA   (Argentina)

Author keywords

Angiogenesis; Cancer; EMT; Extracellular matrix; SPARC

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN TYPE 1; FAS ANTIGEN; INTEGRIN LINKED KINASE; INTERLEUKIN 1; INTERLEUKIN 8; LEUKOTRIENE DERIVATIVE; MATRIX METALLOPROTEINASE; NERVE CELL ADHESION MOLECULE; OSTEONECTIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; SHORT HAIRPIN RNA; SMAD4 PROTEIN; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VASCULOTROPIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER THERAPY; CELL INVASION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION; GENE TARGETING; HUMAN; IMMUNOSURVEILLANCE; INFLAMMATION; MEDICAL TECHNOLOGY; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SPARC GENE; TUMOR CELL;

ANIMALS; DISEASE PROGRESSION; HUMANS; NEOPLASMS; OSTEONECTIN; SIGNAL TRANSDUCTION;

EID: 52549120738     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-008-9146-7     Document Type: Review

References (195)

1. D. Hanahan R. A. Weinberg 2000 The hallmarks of cancer Cell 100 57 70
2. L. A. Liotta E. C. Kohn 2001 The microenvironment of the tumour-host interface Nature 411 375 379
3. J. E. Murphy-Ullrich 2001 The de-adhesion activity of matricellular proteins: Is intermediate cell adhesion an adaptive state? Journal of Clinical Investigation 107 7 785 790
4. P. Bornstein 2002 Cell-matrix interactions: The view from the outside Methods in Cell Biology 69 7 11
5. E. H. Sage 2001 Regulation of interactions between cells and extracellular matrix: A command performance on several stages Journal of Clinical Investigation 107 7 781 783
6. S. Rosenblatt J. A. Bassuk C. E. Alpers E. H. Sage R. Timpl K. T. Preissner 1997 Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: Characterization of the binding of vitronectin to osteonectin (BM40, SPARC) Biochemical Journal 324 311 319
7. R. L. Xie G. L. Long 1995 Role of N-linked glycosylation in human osteonectin. Effect of carbohydrate removal by N-glycanase and site-directed mutagenesis on structure and binding of type V collagen Journal of Biological Chemistry 270 39 23212 23217
8. P. Maurer C. Hohenadl E. Hohenester W. Gohring R. Timpl J. Engel 1995 The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domains that binds calcium and collagen IV Journal of Molecular Biology 253 2 347 357
9. E. W. Raines T. F. Lane M. L. Iruela-Arispe R. Ross E. H. Sage 1992 The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and BB and inhibits the binding of PDGF to its receptors Proceedings of the National Academy of Sciences of the United States of America 89 1281 1285
10. P. Hasselaar E. H. Sage 1992 SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells Journal of Cellular Biochemistry 49 272 283
11. P. M. Tremble T. F. Lane E. H. Sage Z. Werb 1993 SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway Journal of Cell Biology 121 6 1433 1444
12. M. F. Ledda S. Adris A. I. Bravo C. Kairiyama L. Bover Y. Chernajovsky 1997 Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells Nature Medicine 3 2 171 175
13. T. F. Lane M. L. Iruela-Arispe E. H. Sage 1992 Regulation of gene expression by SPARC during angiogenesis in vitro, changes in fibronectin, thrombospondin-1 and plasminogen activator inhibitor-1 Journal of Biological Chemistry 267 23 16736 16745
14. C. Gilles J. A. Bassuk H. Pulyaeva E. H. Sage J.-M. Foidart E. W. Thompson 1998 SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines Cancer Research 58 23 5529 5536
15. J. E. Murphy-Ullrich T. F. Lane M. A. Pallero E. H. Sage 1995 SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca2+ binding EF-hand Journal of Cellular Biochemistry 57 341 350
16. R. A. Brekken E. H. Sage 2000 SPARC, a matricellular protein: At the crossroads of cell-matrix Matrix Biology 19 7 569 580
17. A. D. Bradshaw A. Francki K. Motamed C. Howe E. H. Sage 1999 Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation Molecular Biology of the Cell 10 5 1569 1579
18. M. F. Ledda A. I. Bravo S. Adris L. Bover J. Mordoh O. L. Podhajcer 1997 The expression on the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma Journal of Investigative Dermatology 108 2 210 214
19. G. Rumpler B. Becker C. Hafner M. McClelland W. Stolz M. Landthaler 2003 Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes Experimental Dermatology 12 6 761 771
20. D. Massi A. Franchi L. Borgognoni U. M. Reali M. Santucci 1999 Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas Human Pathology 30 3 339 344
21. Y. Ikuta T. Nakatsura T. Kageshita S. Fukushima S. Ito K. Wakamatsu 2005 Highly sensitive detection of melanoma at an early stage based on the increased serum secreted protein acidic and rich in cysteine and glypican-3 levels Clinical Cancer Research 11 22 8079 8088
22. M. S. Sosa M. R. Girotti E. Salvatierra F. Prada J. A. de Olmo S. J. Gallango 2007 Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells Proteomics 7 22 4123 4134
23. D. J. Smit B. B. Gardiner R. A. Sturm 2007 Osteonectin downregulates E-cadherin, induces osteopontin and focal adhesion kinase activity stimulating an invasive melanoma phenotype International Journal of Cancer 121 12 2653 2660
24. P. L. Porter E. H. Sage T. F. Lane S. E. Funk A. M. Gown 1995 Distribution of SPARC in normal and neoplastic human tissue Journal of Histochemistry and Cytochemistry 43 8 791 800
25. A. Bellahcene V. Castronovo 1995 Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer American Journal of Pathology 146 1 95 100
26. O. L. Podhajcer C. Wolf O. Lefebvre J. P. Segain N. Rouyer I. Stoll 1996 Comparative expression of the SPARC and stromelysin-3 genes in mammary tumors The Breast 5 13 20
27. C. Jones A. Mackay A. Grigoriadis A. Cossu J. S. Reis-Filho L. Fulford 2004 Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer Cancer Research 64 9 3037 3045
28. H. C. Lien Y. H. Hsiao Y. S. Lin Y. T. Yao H. F. Juan W. H. Kuo 2007 Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: Identification of genes potentially related to epithelial-mesenchymal transition Oncogene 26 57 7859 7871
29. P. J. Barth R. Moll A. Ramaswamy 2005 Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast Virchows Archiv 446 5 532 536
30. B. S. Parker P. Argani B. P. Cook H. Liangfeng S. D. Chartrand M. Zhang 2004 Alterations in vascular gene expression in invasive breast carcinoma Cancer Research 64 21 7857 7866
31. C. A. Iacobuzio-Donahue P. Argani P. M. Hempen J. Jones S. E. Kern 2002 The desmoplastic response to infiltrating breast carcinoma: Gene expression at the site of primary invasion and implications for comparisons between tumor types Cancer Research 62 18 5351 5357
32. J. D. Graham R. L. Balleine J. S. Milliken A. M. Bilous C. L. Clarke 1997 Expression of osteonectin mRNA in human breast tumours is inversely correlated with oestrogen receptor content European Journal of Cancer 33 10 1654 1660
33. S. R. Lakhani J. S. Reis-Filho L. Fulford F. Penault-Llorca M. van der Vijver S. Parry 2005 Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype Clinical Cancer Research 11 14 5175 5180
34. G. Watkins A. Douglas-Jones R. Bryce R. E. Mansel W. G. Jiang 2005 Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes Prostaglandins, Leukotrienes and Essential Fatty Acids 72 4 267 272
35. S. A. Rempel W. A. Golembieski S. Ge N. Lemke K. Elisevich T. Mikkelsen 1998 SPARC: A signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas Journal of Neuropathology and Experimental Neurology 57 12 1112 1121
36. W. A. Golembieski S. Ge K. Nelson T. Mikkelsen S. A. Rempel 1999 Increased SPARC expression promotes U87 glioblastoma invasion in vitro International Journal of Developmental Neuroscience 17 5-6 463 472
37. J. N. Rich Q. Shi M. Hjelmeland T. J. Cummings C. T. Kuan D. D. Bigner 2003 Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model Journal of Biological Chemistry 278 18 15951 15957
38. C. Schultz N. Lemke S. Ge W. A. Golembieski S. A. Rempel 2002 Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo Cancer Research 62 6270 6277
39. P. Vajkoczy M. D. Manger R. Goldbrunner S. Ge T. A. Fong B. Vollmar 2000 Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC International Journal of Cancer 87 2 261 268
40. Q. Shi S. Bao J. A. Maxwell E. D. Reese H. S. Friedman D. D. Bigner 2004 Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation Journal of Biological Chemistry 279 50 52200 52209
41. H. M. McClung S. L. Thomas P. Osenkowski M. Toth P. Menon A. Raz 2007 SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells Neuroscience Letters 419 2 172 177
42. A. J. Minn G. P. Gupta P. M. Siegel P. D. Bos W. Shu D. D. Giri 2005 Genes that mediate breast cancer metastasis to lung Nature 436 7050 518 524
43. D. A. Campo-McKnight D. M. Sosnoski J. E. Koblinski C. V. Gay 2006 Roles of osteonectin in the migration of breast cancer cells into bone Journal of Cellular Biochemistry 97 2 288 302
44. K. Jacob M. Webber D. Benayahu H. K. Kleinman 1999 Osteonectin promotes prostate cancer cell migration and invasion: Possible mechanism for metastasis to bone Cancer Research 59 17 4453 4457
45. S. De J. Chen N. V. Narizhneva W. Heston J. Brainard E. H. Sage 2003 molecular pathway for cancer metastasis to bone Journal of Biological Chemistry 278 40 39044 39050
46. N. Chen X. C. Ye K. Chu N. M. Navone E. H. Sage L. Y. Yu-Lee 2007 A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells Cancer Research 67 14 6544 6548
47. J. E. Koblinski B. R. Kaplan-Singer S. J. VanOsdol M. Wu J. A. Engbring S. Wang 2005 Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis Cancer Research 65 16 7370 7377
48. G. Finocchiaro F. M. Mancuso D. Cittaro H. Muller 2007 Graph-based identification of cancer signaling pathways from published gene expression signatures using PubLiME Nucleic Acids Research 35 7 2343 2355
49. A. Chlenski S. Liu S. E. Crawford O. V. Volpert G. H. DeVries A. Evangelista 2002 SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis Cancer Research 62 24 7357 7363
50. A. Chlenski S. Liu L. J. Baker Q. Yang Y. Tian H. R. Salwen 2004 Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC Cancer Research 64 20 7420 7425
51. N. Said M. J. Socha J. J. Olearczyk A. A. Elmarakby J. D. Imig K. Motamed 2007 Normalization of the ovarian cancer microenvironment by SPARC Molecular Cancer Research 5 10 1015 1030
52. N. A. Said I. Najwer M. J. Socha D. J. Fulton S. C. Mok K. Motamed 2007 SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk Neoplasia 9 1 23 35
53. G. K. Yiu W. Y. Chan S. W. Ng P. S. Chan K. K. Cheung R. S. Berkowitz 2001 SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells American Journal of Pathology 159 2 609 622
54. S. C. Mok W. Y. Chan K. K. Wong M. G. Muto R. S. Berkowitz 1996 SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells Oncogene 12 1895 1901
55. N. Said K. Motamed 2005 Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis American Journal of Pathology 167 6 1739 1752
56. T. J. Brown P. A. Shaw X. Karp M. H. Huynh H. Begley M. J. Ringuette 1999 Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer Gynecologic Oncology 75 1 25 33
57. I. T. Tai M. Dai D. A. Owen L. B. Chen 2005 Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy Journal of Clinical Investigation 115 6 1492 1502
58. F. Taghizadeh M. J. Tang I. T. Tai 2007 Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy Molecular Cancer Therapeutics 6 1 309 317
59. M. J. Tang I. T. Tai 2007 A novel interaction between procaspase 8 and SPARC enhances apoptosis and potentiates chemotherapy sensitivity in colorectal cancers Journal of Biological Chemistry 282 47 34457 34467
60. E. Yang H. J. Kang K. H. Koh H. Rhee N. K. Kim H. Kim 2007 Frequent inactivation of SPARC by promoter hypermethylation in colon cancers International Journal of Cancer 121 3 567 575
61. A. H. Wiese J. Auer S. Lassmann J. Nahrig R. Rosenberg H. Hofler 2007 Identification of gene signatures for invasive colorectal tumor cells Cancer Detection and Prevention 31 4 282 295
62. Q. D. Nguyen O. De Wever E. Bruyneel A. Hendrix W. Z. Xie A. Lombet 2005 Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho-Rho kinase axis and tumor microenvironment Oncogene 24 56 8240 8251
63. H. Porte E. Chastre S. Prevot B. Nordlinger S. Empereur P. Basset 1995 Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes International Journal of Cancer 64 70 75
64. A. Guweidhi J. Kleeff H. Adwan N. A. Giese M. N. Wente T. Giese 2005 Osteonectin influences growth and invasion of pancreatic cancer cells Annals of Surgery 242 2 224 234
65. J. R. Infante H. Matsubayashi N. Sato J. Tonascia A. P. Klein T. A. Riall 2007 Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma Journal of Clinical Oncology 25 3 319 325
66. M. I. Koukourakis A. Giatromanolaki R. A. Brekken E. Sivridis K. C. Gatter A. L. Harris 2003 Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients Cancer Research 63 17 5376 5380
67. N. Sato N. Fukushima N. Maehara H. Matsubayashi J. Koopmann G. H. Su 2003 SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions Oncogene 22 32 5021 5030
68. C. López-Haber V. Gottifredi A. S. Llera E. Salvatierra F. Prada L. Alonso 2008 SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated International Journal of Cancer 122 7 1465 1475
69. F. Prada L. G. Benedetti A. I. Bravo M. J. Alvarez C. Carbone O. L. Podhajcer 2007 SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth Journal of Investigative Dermatology 127 11 2618 2628
70. R. A. Brekken P. Puolakkainen D. C. Graves G. Workman S. R. Lubkin E. H. Sage 2003 Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM Journal of Clinical Investigation 111 4 487 495
71. S. Sangaletti A. Stoppacciaro C. Guiducci M. R. Torrisi M. P. Colombo 2003 Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma Journal of Experimental Medicine 198 10 1475 1485
72. P. E. Framson E. H. Sage 2004 SPARC and tumor growth: Where the seed meets the soil? Journal of Cellular Biochemistry 92 4 679 690
73. M. D. Gooden R. B. Vernon J. A. Bassuk E. H. Sage 1999 Cell cycle-dependent nuclear location of the matricellular protein SPARC: Association with the nuclear matrix Journal of Cellular Biochemistry 74 2 152 167
74. J. Sodek B. Zhu M. H. Huynh T. J. Brown M. Ringuette 2002 Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC Connective Tissue Research 43 2-3 308 319
75. Q. Yan M. Weaver N. Perdue E. H. Sage 2005 Matricellular protein SPARC is translocated to the nuclei of immortalized murine lens epithelial cells Journal of Cellular Physiology 203 1 286 294
76. E. H. Sage C. Johnson P. Bornstein 1984 Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture Journal of Biological Chemistry 259 3993 4007
77. S. E. Funk E. H. Sage 1993 Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts Journal of Cellular Physiology 154 53 63
78. 2+-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells Proceedings of the National Academy of Sciences of the United States of America 88 2648 2652
79. C. Kupprion K. Motamed E. H. Sage 1998 SPARC (BM-40, Osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells Journal of Biological Chemistry 273 45 29635 29640
80. C. P. Lau R. T. Poon S. T. Cheung W. C. Yu S. T. Fan 2006 SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma Journal of Pathology 210 4 459 468
81. A. Charest A. Pepin R. Shetty C. Cote P. Voisine F. Dagenais 2006 Distribution of SPARC during neovascularisation of degenerative aortic stenosis Heart 92 12 1844 1849
82. M. L. Iruela Arispe T. F. Lane D. Redmond M. Reilly R. P. Bolender T. J. Kavanagh 1995 Expression of SPARC during development of the chicken chorioallantoic membrane: Evidence for regulated proteolysis in vivo Molecular Biology of the Cell 6 3 327 343
83. T. F. Lane M. L. Iruela-Arispe R. S. Johnson E. H. Sage 1994 SPARC is a source of copper-binding peptides that stimulate angiogenesis Journal of Cell Biology 125 929 943
84. E. H. Sage M. Reed S. E. Funk T. Truong M. Steadele P. Puolakkainen 2003 Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis Journal of Biological Chemistry 278 39 37849 37857
85. T. Sasaki N. Miosge R. Timpl 1999 Immunochemical and tissue analysis of protease generated neoepitopes of BM-40 (osteonectin, SPARC) which are correlated to a higher affinity binding to collagens Matrix Biology 18 5 499 508
86. Y. Kato J. M. Lewalle Y. Baba M. Tsukuda N. Sakai M. Baba 2001 Induction of SPARC by VEGF in human vascular endothelial cells Biochemical and Biophysical Research Communications 287 2 422 426
87. M. Nozaki E. Sakurai B. J. Raisler J. Z. Baffi J. Witta Y. Ogura 2006 Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A Journal of Clinical Investigation 116 2 422 429
88. G. Ferrari G. Pintucci G. Seghezzi K. Hyman A. C. Galloway P. Mignatti 2006 VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis Proceedings of the National Academy of Sciences of the United States of America 103 46 17260 17265
89. M. E. Choi B. J. Ballermann 1995 Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptors Journal of Biological Chemistry 270 36 21144 21150
90. J. P. Thiery 2002 Epithelial-mesenchymal transitions in tumour progression Nature Reviews. Cancer 2 6 442 454
91. A. Cano M. A. Perez-Moreno I. Rodrigo A. Locascio M. J. Blanco M. G. del Barrio 2000 The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression Nature Cell Biology 2 2 76 83
92. B. De Craene F. van Roy G. Berx 2005 Unraveling signalling cascades for the Snail family of transcription factors Cellular Signalling 17 5 535 547
93. G. Moreno-Bueno E. Cubillo D. Sarrio H. Peinado S. M. Rodriguez-Pinilla S. Villa 2006 Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition Cancer Research 66 19 9543 9556
94. G. Robert C. Gaggioli O. Bailet C. Chavey P. Abbe E. Aberdam 2006 SPARC represses E-cadherin and induces mesenchymal transition during melanoma development Cancer Research 66 15 7516 7523
95. S. R. Alonso L. Tracey P. Ortiz B. Perez-Gomez J. Palacios M. Pollan 2007 A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis Cancer Research 67 7 3450 3460
96. B. Bierie H. L. Moses 2006 Tumour microenvironment: TGFbeta: The molecular Jekyll and Hyde of cancer Nature Reviews. Cancer 6 7 506 520
97. R. Ford G. Wang P. Jannati D. Adler P. Racanelli P. J. Higgins 1993 Modulation of SPARC expression during butyrate-induced terminal differentiation of cultured human keratinocytes: Regulation via a TGF-beta-dependent pathway Experimental Cell Research 206 2 261 275
98. J. A. Bassuk R. Pichler J. D. Rothmier J. Pippen K. Gordon R. L. Meek 2000 Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis Kidney International 57 1 117 128
99. A. Francki A. D. Bradshaw J. A. Bassuk C. C. Howe W. G. Couser E. H. Sage 1999 SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells Journal of Biological Chemistry 274 45 32145 32152
100. M. J. Reed R. B. Vernon I. B. Abrass E. H. Sage 1994 TGF-b 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors Journal of Cellular Physiology 158 1 169 179
101. H. Shiba Y. Uchida K. Kamihagi M. Sakata T. Fujita S. Nakamura 2001 Transforming growth factor-beta1 and basic fibroblast growth factor modulate osteocalcin and osteonectin/SPARC syntheses in vitamin-D-activated pulp cells Journal of Dental Research 80 7 1653 1659
102. J. L. Wrana C. M. Overall J. Sodek 1991 Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen European Journal of Biochemistry 197 519 528
103. P. Pavasant T. Yongchaitrakul K. Pattamapun M. Arksornnukit 2003 The synergistic effect of TGF-beta and 1,25-dihydroxyvitamin D3 on SPARC synthesis and alkaline phosphatase activity in human pulp fibroblasts Archives of Oral Biology 48 10 717 722
104. A. Francki T. D. McClure R. A. Brekken K. Motamed C. Murri T. Wang 2004 SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells Journal of Cellular Biochemistry 91 5 915 925
105. B. J. Schiemann J. R. Neil W. P. Schiemann 2003 SPARC inhibits epithelial cell proliferation in part through stimulation of the TGF-beta-signaling system Molecular Biology of the Cell 14 10 3977 3988
106. A. D. Bradshaw M. J. Reed J. G. Carbon E. Pinney R. A. Brekken E. H. Sage 2001 Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice Wound Repair and Regeneration 9 6 522 530
107. H. Peinado M. Quintanilla A. Cano 2003 Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: Mechanisms for epithelial mesenchymal transitions Journal of Biological Chemistry 278 23 21113 21123
108. G. W. McLean N. O. Carragher E. Avizienyte J. Evans V. G. Brunton M. C. Frame 2005 The role of focal-adhesion kinase in cancer-A new therapeutic opportunity Nature Reviews. Cancer 5 7 505 515
109. Q. Shi S. Bao L. Song Q. Wu D. D. Bigner A. B. Hjelmeland 2007 Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases Oncogene 26 28 4084 4094
110. L. M. Coussens Z. Werb 1996 Matrix metalloproteinases and the development of cancer Chemistry & Biology 3 895 904
111. M. J. Alvarez F. Prada E. Salvatierra A. I. Bravo V. P. Lutzky C. Carbone 2005 Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity Cancer Research 65 12 5123 5132
112. R. C. Savani Z. Zhou E. Arguiri S. Wang D. Vu C. C. Howe 2000 Bleomycin-induced pulmonary injury in mice deficient in SPARC AJP-Lung Cellular and Molecular Physiology 279 4 L743 L750
113. S. Sangaletti L. Gioiosa C. Guiducci G. Rotta M. Rescigno A. Stoppacciaro 2005 Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice Journal of Cell Science 118 Pt 16 3685 3694
114. S. A. Rempel R. C. Hawley J. A. Gutierrez E. Mouzon K. R. Bobbitt N. Lemke 2007 Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response Genes and Immunity 8 3 262 274
115. C. Vannahme S. Gosling M. Paulsson P. Maurer U. Hartmann 2003 Characterization of SMOC-2, a modular extracellular calcium-binding protein Biochemical Journal 373 Pt 3 805 814
116. E. F. Rocnik P. Liu K. Sato K. Walsh C. Vaziri 2006 The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity Journal of Biological Chemistry 281 32 22855 22864
117. J.-P. Girard T. A. Springer 1995 Cloning from purified high endothelial venule cells of hevin, a close relative of the antiadhesive extracellular matrix protein SPARC Immunity 2 113 123
118. J.-P. Girard T. A. Springer 1996 Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules Journal of Biological Chemistry 271 8 4511 4517
119. P. S. Nelson S. R. Plymate K. Wang L. D. True J. L. Ware L. Gan 1998 Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma Cancer Research 58 2 232 236
120. I. Bendik P. Schraml C. U. Ludwig 1998 Characterization of MAST9/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancer Cancer Research 58 4 626 629
121. A. Claeskens N. Ongenae J. M. Neefs P. Cheyns P. Kaijen M. Cools 2000 Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation British Journal of Cancer 82 6 1123 1130
122. I. Esposito H. Kayed S. Keleg T. Giese E. H. Sage P. Schirmacher 2007 Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer Neoplasia 9 1 8 17
123. A. A. Jazaeri C. S. Awtrey G. V. Chandramouli Y. E. Chuang J. Khan C. Sotiriou 2005 Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers Clinical Cancer Research 11 17 6300 6310
124. J. Briggs S. Chamboredon M. Castellazzi J. A. Kerry T. J. Bos 2002 Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells Oncogene 21 46 7077 7091
125. M. V. Lopez P. Blanco D. L. Viale E. G. Cafferata C. Carbone D. Gould 2006 Expression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth Molecular Cancer Therapeutics 5 10 2503 2511
126. D. A. Zajchowski M. F. Bartholdi Y. Gong L. Webster H.-L. Liu A. Munishkin 2001 Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells Cancer Research 61 13 5168 5178
127. U. Woelfle J. Cloos G. Sauter L. Riethdorf F. Janicke P. van Diest 2003 Molecular signature associated with bone marrow micrometastasis in human breast cancer Cancer Research 63 18 5679 5684
128. G. Watkins T. A. Martin R. Bryce R. E. Mansel W. G. Jiang 2005 Gamma-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells Prostaglandins, Leukotrienes and Essential Fatty Acids 72 4 273 278
129. V. Castronovo A. Bellahcene 1998 Evidence that breast cancer associated microcalcifications are mineralized malignant cells International Journal of Oncology 12 2 305 308
130. D. Porter J. Lahti-Domenici A. Keshaviah Y. K. Bae P. Argani J. Marks 2003 Molecular markers in ductal carcinoma in situ of the breast Molecular Cancer Research 1 5 362 375
131. S. H. Dairkee Y. Ji Y. Ben D. H. Moore Z. Meng S. S. Jeffrey 2004 A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue BMC Genomics 5 47
132. S. Amatschek U. Koenig H. Auer P. Steinlein M. Pacher A. Gruenfelder 2004 Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes Cancer Research 64 3 844 856
133. M. P. H. M. Jansen J. A. Foekens I. L. van Staveren M. M. Dirkzwager-Kiel K. Ritstier M. P. Look 2005 Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling Journal of Clinical Oncology 23 4 732 740
134. 3 integrin in human radial growth phase primary melanoma cells Cancer Research 62 226 232
135. S. Kuphal H. G. Palm I. Poser A. K. Bosserhoff 2005 Snail-regulated genes in malignant melanoma Melanoma Research 15 4 305 313
136. P. M. Menon J. A. Gutierrez S. A. Rempel 2000 A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: High SPARC secretion correlates with decreased migration on vitronectin International Journal of Oncology 17 4 683 693
137. H. Huang S. Colella M. Kurrer Y. Yonekawa P. Kleihues H. Ohgaki 2000 Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays Cancer Research 60 24 6868 6874
138. S. A. Rempel W. A. Golembieski J. L. Fisher M. Maile A. Nakeff 2001 SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins Journal of Neuro-oncology 53 149 160
139. W. A. Golembieski S. A. Rempel 2002 cDNA array analysis of SPARC-modulated changes in glioma gene expression Journal of Neuro-oncology 60 3 213 226
140. X. Zhou F. K. Tan X. Guo D. Wallis D. M. Milewicz S. Xue 2005 Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts Arthritis and Rheumatism 52 1 257 261
141. G. Cantarella N. Risuglia R. Dell'eva L. Lempereur A. Albini G. Pennisi 2006 TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells British Journal of Cancer 94 10 1428 1435
142. S. Kunigal C. S. Gondi M. Gujrati S. S. Lakka D. H. Dinh W. C. Olivero 2006 SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA International Journal of Oncology 29 6 1349 1357
143. N. Gagliano C. Moscheni C. Torri I. Magnani A. A. Bertelli W. Nowicky 2006 Effect of Ukrain on matrix metalloproteinase-2 and secreted protein acidic and rich in cysteine (SPARC) expression in human glioblastoma cells Anticancer Drugs 17 2 189 194
144. C. Colin N. Baeza C. Bartoli F. Fina N. Eudes I. Nanni 2006 Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using suppression subtractive hybridization Oncogene 25 19 2818 2826
145. S. A. Rempel S. Ge J. A. Gutiérrez 1999 SPARC: A potential diagnostic marker of invasive meningiomas Clinical Cancer Research 5 237 241
146. J. N. Rich C. Hans B. Jones E. S. Iversen R. E. McLendon B. K. Rasheed 2005 Gene expression profiling and genetic markers in glioblastoma survival Cancer Research 65 10 4051 4058
147. M. W. Volmer Y. Radacz S. A. Hahn S. Klein-Scory K. Stuhler M. Zapatka 2004 Tumor suppressor Smad4 mediates downregulation of the anti-adhesive invasion-promoting matricellular protein SPARC: Landscaping activity of Smad4 as revealed by a "secretome" analysis Proteomics 4 5 1324 1334
148. O. J. Sansom F. C. Mansergh M. J. Evans J. A. Wilkins A. R. Clarke 2007 Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice Gut 56 10 1410 1414
149. J. Madoz-Gurpide P. Lopez-Serra J. L. Martinez-Torrecuadrada L. Sanchez
150. S. Kaiser Y. K. Park J. L. Franklin R. B. Halberg M. Yu W. J. Jessen 2007 Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer Genome Biology 8 R131
151. V. Lecrone W. Li R. E. Devoll C. Logothetis M. C. Farach-Carson 2000 Calcium signals in prostate cancer cells: Specific activation by bone-matrix proteins Cell Calcium 27 1 35 42
152. R. Thomas L. D. True J. A. Bassuk P. H. Lange R. L. Vessella 2000 Differential expression of osteonectin/SPARC during human prostate cancer progression Clinical Cancer Research 6 3 1140 1149
153. J. Lapointe C. Li J. P. Higgins M. van de Rijn E. Bair K. Montgomery 2004 Gene expression profiling identifies clinically relevant subtypes of prostate cancer Proceedings of the National Academy of Sciences of the United States of America 101 3 811 816
154. C. J. Best J. W. Gillespie Y. Yi G. V. Chandramouli M. A. Perlmutter Y. Gathright 2005 Molecular alterations in primary prostate cancer after androgen ablation therapy Clinical Cancer Research 11 19 Pt 1 6823 6834
155. Y. Kato N. Sakai M. Baba S. Kaneko K. Kondo Y. Kubota 1998 Stimulation of motility of human renal cell carcinoma by SPARC/Osteonectin/BM-40 associated with type IV collagen Invasion Metastasis 18 2 105 114
156. N. Sakai M. Baba Y. Nagasima Y. Kato K. Hirai K. Kondo 2001 SPARC expression in primary human renal cell carcinoma: Upregulation of SPARC in sarcomatoid renal carcinoma Human Pathology 32 10 1064 1070
157. M. A. Gieseg T. Cody M. Z. Man S. J. Madore M. A. Rubin E. P. Kaldjian 2002 Expression profiling of human renal carcinomas with functional taxonomic analysis BMC Bioinformatics 3 26
158. A. Luo J. Kong G. Hu C. C. Liew M. Xiong X. Wang 2004 Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray Oncogene 23 6 1291 1299
159. M. Mitas J. S. Almeida K. Mikhitarian W. E. Gillanders D. N. Lewin D. D. Spyropoulos 2005 Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR Clinical Cancer Research 11 6 2205 2214
160. Y. Che A. Luo H. Wang J. Qi J. Guo Z. Liu 2006 The differential expression of SPARC in esophageal squamous cell carcinoma International Journal of Molecular Medicine 17 6 1027 1033
161. H. Porte J. P. Triboulet L. Kotelevets F. Carrat S. Prevot B. Nordlinger 1998 Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: Implications for prognosis Clinical Cancer Research 4 6 1375 1382
162. K. Yamashita S. Upadhay K. Mimori H. Inoue M. Mori 2003 Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression Cancer 97 10 2412 2419
163. J. Brabender P. Marjoram R. V. Lord R. Metzger D. Salonga D. Vallbohmer 2005 The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma Cancer Epidemiology, Biomarkers & Prevention 14 9 2113 2117
164. F. Siddiq F. H. Sarkar A. Wali H. I. Pass F. Lonardo 2004 Increased osteonectin expression is associated with malignant transformation and tumor associated fibrosis in the lung Lung Cancer 45 2 197 205
165. J. De Vos T. Thykjaer K. Tarte M. Ensslen P. Raynaud G. Requirand 2002 Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays Oncogene 21 44 6848 6857
166. C. V. Hedvat R. L. Comenzo J. Teruya-Feldstein A. B. Olshen S. A. Ely K. Osman 2003 Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myeloma British Journal of Haematology 122 5 728 744
167. N. Martinez F. I. Camacho P. Algara A. Rodriguez A. Dopazo E. Ruiz-Ballesteros 2003 The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival Cancer Research 63 23 8226 8232
168. A. Aouacheria V. Navratil R. Lopez-Perez N. C. Gutierrez A. Churkin D. Barash 2007 In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions BMC Genomics 8 2
169. M. Bloomston E. C. Ellison P. Muscarella O. Al-Saif E. W. Martin W. S. Melvin 2007 Stromal osteonectin overexpression is associated with poor outcome in patients with ampullary cancer Annals of Surgical Oncology 14 1 211 217
170. K. L. Prenzel U. Warnecke-Eberz H. Xi J. Brabender S. E. Baldus E. Bollschweiler 2006 Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater Oncology Reports 15 5 1397 1401
171. B. Le Bail S. Faouzi L. Boussarie J. Guirouilh J. F. Blanc J. Carles 1999 Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma Journal of Pathology 189 1 46 52
172. D. Goldenberg S. Ayesh T. Schneider O. Pappo O. Jurim A. Eid 2002 Analysis of differentially expressed genes in hepatocellular carcinoma using cDNA arrays Molecular Carcinogenesis 33 113 124
173. H. Y. Maeng S. B. Song D. K. Choi K. E. Kim H. Y. Jeong Y. Sakaki 2002 Osteonectin-expressing cells in human stomach cancer and their possible clinical significance Cancer Letters 184 1 117 121
174. H. Inoue A. Matsuyama K. Mimori H. Ueo M. Mori 2002 Prognostic score of gastric cancer determined by cDNA microarray Clinical Cancer Research 8 11 3475 3479
175. C. S. Wang K. H. Lin S. L. Chen Y. F. Chan S. Hsueh 2004 Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance British Journal of Cancer 91 11 1924 1930
176. P. J. Paley B. A. Goff A. M. Gown B. E. Greer E. H. Sage 2000 Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer Gynecologic Oncology 78 3 Pt 1 336 341
177. W. Nimphius R. Moll P. Olbert A. Ramaswamy P. J. Barth 2007 CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder Virchows Archiv 450 2 179 185
178. M. Yamanaka K. Kanda N.-C. Li T. Fukumori N. Oka H.-O. Kanayama 2001 Analysis of the gene expression of SPARC and its prognostic value for bladder cancer Journal of Urology 166 2495 2499
179. Y. Chen C. Miller R. Mosher X. Zhao J. Deeds M. Morrissey 2003 Identification of cervical cancer markers by cDNA and tissue microarrays Cancer Research 63 8 1927 1935
180. P. Sova Q. Feng G. Geiss T. Wood R. Strauss V. Rudolf 2006 Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis Cancer Epidemiology, Biomarkers & Prevention 15 1 114 123
181. F. J. Rodriguez-Jimenez T. Caldes P. Iniesta J. A. Vidart J. L. Garcia-Asenjo M. Benito 2007 Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma Oncology Reports 17 6 1301 1307
182. J. C. Fanburg-Smith G. L. Bratthauer M. Miettinen 1999 Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: A study of 28 cases Human Pathology 30 1 32 38
183. C. A. Dalla-Torre M. Yoshimoto C. H. Lee A. M. Joshua S. R. de Toledo A. S. Petrilli 2006 Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma BMC Cancer 6 1 237
184. T. Takano Y. Hasegawa A. Miyauchi F. Matsuzuka H. Yoshida K. Kuma 2002 Quantitative analysis of osteonectin mRNA in thyroid carcinomas Endocrine Journal 49 4 511 516
185. D. Chin G. M. Boyle R. M. Williams K. Ferguson N. Pandeya J. Pedley 2005 Novel markers for poor prognosis in head and neck cancer International Journal of Cancer 113 5 789 797
186. R. L. Aycock A. C. Bradshaw E. H. Sage B. Starcher 2004 Development of UV-induced squamous cell carcinomas is suppressed in the absence of SPARC Journal of Investigative Dermatology 123 3 592 599
187. N. Said I. Najwer K. Motamed 2007 Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer American Journal of Pathology 170 3 1054 1063
188. N. A. Cody V. Ouellet E. N. Manderson M. C. Quinn A. Filali-Mouhim P. Tellis 2007 Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p Oncogene 26 4 618 632
189. N. Dhanesuan J. A. Sharp T. Blick J. T. Price E. W. Thompson 2002 Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition Breast Cancer Research and Treatment 75 1 73 85
190. A. Bergamaschi E. Tagliabue T. Sorlie B. Naume T. Triulzi R. Orlandi 2007 Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome Journal of Pathology 214 3 357 367
191. H. Tang J. Wang F. Bai L. Hong J. Liang J. Gao 2007 Inhibition of osteopontin would suppress angiogenesis in gastric cancer Biochemistry and Cell Biology 85 1 103 110
192. A. Chlenski S. Liu L. J. Guerrero Q. Yang Y. Tian H. R. Salwen 2006 SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix International Journal of Cancer 118 2 310 316
193. A. Chlenski L. J. Guerrero Q. Yang Y. Tian R. Peddinti H. R. Salwen 2007 SPARC enhances tumor stroma formation and prevents fibroblast activation Oncogene 26 31 4513 4522
194. P. Puolakkainen A. D. Bradshaw T. R. Kyriakides M. Reed R. Brekken T. Wight 2003 Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials American Journal of Pathology 162 2 627 635
195. J. F. DiMartino N. J. Lacayo M. Varadi L. Li C. Saraiya Y. Ravindranath 2006 Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein Leukemia 20 3 426 432